Akebia’s Vafseo (vadadustat) Poised to Make Waves for GSK’s Jesduvroq and…
Exton, Pennsylvania, July 20, 2023 (GLOBE NEWSWIRE) -- Nephrologists have long awaited the approval of HIF-PH inhibitors for the treatment of anemia in their chronic kidney disease (CKD)…